Quoted securities:

25,346,067 fully paid ordinary shares

ASX code: 

RAC

Time: 

11:00 AM (AEST)

Date:

Wednesday, 13 July 2016

ASX Trade abbreviation: 

RACEONCO

ISIN:

AU000000RAC3

Home branch: 

Perth

Industry classification: 

To be advised.

Registered office: 

Principal place of business

As above.

Company secretary: 

Mr Peter Webse and Mr Damon Sweeny (joint company secretaries)

Share registry:

Balance date:

30 June

CHESS: 

Participating. The Company will also operate an issuer sponsored sub-register.

Dividend policy:

See section 3.15 on page 13 of the Company’s prospectus dated 11 May 2016.

Activities:

Development of cancer drug, Bisantrene.

Restricted securities: 

27,341,434 fully paid ordinary shares, classified by ASX as restricted securities to be held in escrow for a period of 24 months from the date of quotation.

10,000,000 performance shares, classified by ASX as restricted securities to be held in escrow for a period of 24 months from the date of quotation.

9,000,000 options exercisable at $0.25 and expiring 1 July 2021, classified by ASX as restricted securities to be held in escrow for a period of 24 months from the date of quotation.

10,000,000 options exercisable at $0.25 and expiring 1 July 2018, classified by ASX as restricted securities to be held in escrow for a period of 24 months from the date of quotation.

Unquoted Securities:

N/A